GST enzyme activity is significantly lower among individuals with 105Val allele due to polymorphism at nucleotide 313 in the GSTP1 gene. GST genotypes conferring lower enzyme activity may be of advantage for individuals undergoing chemotherapeutic treatment for neoplastic disease because reduced detoxification potentially enhances effectiveness of cytotoxic drugs.